ACM
REPL icon

ACT Capital Management’s Replimune Group REPL Stock Holding History

ACT Capital Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Hold
61,500
– – 0.37% 34
2025
Q4 		$598K Buy
+61,500
New +$523K 0.48% 32

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACT Capital Management's REPL Position: Q1 2026 in Review

ACT Capital Management held its Replimune Group (REPL) position steady in Q1 2026 at 61,500 shares worth $470K. The position accounts for 0.37% of the portfolio, ranked #34.

ACT Capital Management first reported a position in REPL in Q4 2025 and has held it in 2 quarters since. The position peaked at $598K in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • ACT Capital Management held 61,500 shares of Replimune Group worth $470K as of Q1 2026.
  • ACT Capital Management left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up 0.37% of ACT Capital Management's portfolio in Q1 2026, its #34 holding.
  • ACT Capital Management first reported a position in Replimune Group in Q4 2025 and has held it in 2 quarters since.
  • ACT Capital Management's Replimune Group position peaked at $598K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on ACT Capital Management's 13F filing for Q1 2026, filed 8 May 2026.